(continued)
- Idelvion (Factor IX, Recombinant/Albumin Fusion Protein)
- Ixinity (Factor IX Human, Recombinant)
- Rixubis (Factor IX Human, Recombinant)
- Alprolix (Factor IX Human, Recombinant/Fc Fusion Protein)
- Rebinyn (Factor IX Human Recombinant, Glycopegylated)
- BeneFix (Factor IX Human, Recombinant)
- Nilotinib (Danziten, Tasigna)
- Humate P (Antihemophilic Factor/von Willebrand Factor Complex)
- Daybue (Trofinetide)
- Alphanate (Antihemophilic factor/von Willebrand Factor Complex)
- Besremi (Ropeginterferon Alfa-2b)
- Denosumab (Osenvelt, Wyost, Xgeva)
- Cabozantinib (Cabometyx, Cometriq)
- Imatinib (Gleevec, Imkeldi)
- Dasatinib (Sprycel, Phyrago)
- Revuforj (Revumenib)
- Tretinoin (Vesanoid)
- Xospata (Gilteritinib)
- Vitrakvi (larotrectinib)
- Rozlytrek (entrectinib)
- Vanflyta (quizartinib)
- Vizimpro (dacomitinib)
- Zynteglo (betibeglogene autotemcel)
- Caprelsa (Vandetanib)
- Lapatinib (Tykerb)
- Iclusig (Ponatinib)
- Hemofil M (antihemophilic factor, human)
- Sorafenib (Nexavar)
- Turalio (Pexidartinib)
- Tukysa (tucatinib)
- How Does Enhertu Work for Breast Cancer?
- How Pluvicto Fights Prostate Cancer and What to Expect